Posts
Posts
What Is GHK-Cu, And Should You Use It?
GHK-Cu is backed by 50 years of research, and clinical trials have shown it reduces wrinkles by 55%. On the other hand, it is also listed on the FDA’s restricted substances list. Both of these are true, but why?
A Naturally Occurring Copper Peptide
GHK-Cu is a small molecule formed when three amino acids, glycine, histidine, and lysine, bind with copper ions.
It was discovered in 1973 by biochemist Loren Pickart. He noticed that there was something in the blood of young people that appeared to “reset” liver cells derived from older donors. That substance turned out to be GHK, which binds strongly to copper and exists in the body as the GHK-Cu complex.
What makes GHK-Cu interesting is that its levels in the body appear to decline with age. Around age 20, the plasma concentration is approximately 200 ng/mL. By age 60, it drops to about 80 ng/mL.
GHK-Cu is associated with processes such as wound healing, collagen production, and skin repair. When levels decline, the skin tends to heal more slowly, become thinner, and produce less collagen. This is one of the reasons GHK-Cu became popular in skincare in the first place: because it is connected to the repair signals that young skin naturally relies on.
What the Research Shows
Compared to many peptides currently used in skincare, GHK-Cu has been studied for a long time. Researchers have been investigating it for over 50 years, and its basic mechanisms are fairly well understood.
In laboratory and animal studies, GHK-Cu appears to support several repair-related processes. For example, even at very low concentrations, it can stimulate fibroblasts, the cells responsible for collagen production.
It also seems to be involved in regulating enzymes that break down old collagen, increasing antioxidant activity, and influencing genes involved in tissue repair and remodeling.
While evidence in humans is more limited, it is nonetheless intriguing.
- In a 12-week study, Leyden et al. tested a GHK-Cu-formulated face cream on 71 women with photoaged skin. The cream was applied twice daily. At the end of the study, skin density and thickness improved, and fine lines decreased; the GHK-Cu cream showed superior results compared to both the placebo and the vitamin C control.
- Another study by Badenhorst et al. examined GHK-Cu delivered via a nano-lipid carrier. In this trial, wrinkle volume decreased by 55.8% compared to a control serum and by 31.6% compared to Matrixyl 3000.
- A more recent 2023 industry report also reported a 28% increase in collagen after three months.
It is important to note that these human studies involved the direct application of GHK-Cu to the skin and did not test it as an injectable or systemic anti-aging treatment.
Therefore, claims regarding its use in skincare, particularly concerning skin repair, texture, collagen, and photoaging, can be said to be fairly well-supported.
On the other hand, claims regarding systemic anti-aging, recovery, and longevity associated with injectable GHK-Cu are mostly based on laboratory and animal studies.
So Why Is GHK-Cu Both Legal and Restricted?
GHK-Cu does not fit neatly into a single category. This is because topical GHK-Cu and other uses of it are distinct.
In the United States, GHK-Cu can be used as a cosmetic ingredient and has been used that way for many years. In 2023, the FDA added GHK-Cu to Category 1 of the 503A list of bulk drug substances. This means that compounding pharmacies can use it in certain formulations, but it is explicitly excluded for injection routes. The agency has stated that it will review whether to include GHK-Cu more broadly by February 2027.
GHK-Cu for injection is a completely different matter.
The FDA initially classified this as Category 2 in 2023, citing safety concerns regarding aggregates and peptide impurities that could trigger immune reactions. While the injectable form was removed from Category 2 in April 2026, it was not added to Category 1; it remains under regulatory review pending the PCAC’s decision in February 2027.
In other words, compounding pharmacies still cannot legally prepare GHK-Cu for injection, and the FDA’s fundamental safety concerns remain unresolved.
This presents a significant risk.
Research-chemical vendors may still be selling vials online that appear to be for injection. However, this does not mean they are approved, sterile, properly tested, or safe to inject.
Therefore, if someone asks, “Is GHK-Cu safe?” The honest answer is “It depends.”
If it’s a topical product from a reputable skincare brand, that’s one thing. Injecting a research-grade vial purchased online at home is an entirely different matter.
How Can You Tell Which GHK-Cu Products are Worth Buying?
There are three things you need to know. And many products get at least one of these wrong.
Make sure it’s not for injection
This is the most important rule. The FDA has identified injectable GHK-Cu as risky, and for good reason. The only legitimate routes of administration are topical and oral.
Examine delivery systems
This is where many products fall short.
While a basic GHK-Cu cream is better than nothing, standard GHK-Cu can be unstable. It may be susceptible to oxidation, pH fluctuations, and poor skin penetration, limiting the amount that reaches the skin layers where it is supposed to act.
Oral GHK-Cu faces similar issues. Because GHK-Cu is a small peptide, it can be broken down by stomach acid and digestive enzymes before reaching the bloodstream.
Liposomal encapsulation is the solution to these two problems, as documented in the literature. It uses a phospholipid layer to help protect the peptide until it enters the body, whether through the skin or the intestines. And the study mentioned earlier, which showed the strongest results, addressed this very point.
Verify Quality Testing
Since copper peptides are sensitive to manufacturing quality, third-party testing should be a minimum requirement. Be sure to check for a current Certificate of Analysis (COA) from an unbiased third-party laboratory.
Why Is Oral GHK-Cu Part of the Discussion?
This brings us back to the beginning of this article. Plasma concentrations decline significantly with age, and this decline is systemic. Therefore, it cannot be addressed solely with a topical cream applied to the skin.
If the goal is systemic support, the product must have a route capable of reaching the bloodstream.
Injections are one route, but they come with safety concerns.
A properly encapsulated oral form is another route. And that is what LVLUP’s liposomal GHK-Cu is. It is non-injectable, liposomal, and third-party tested.
In a category divided between basic creams that remain primarily topical and injectable products for which the FDA has issued warnings, this third option offers protected delivery, systemic access, and the absence of injection risks.
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
Related Products
Formulas mentioned in this post
Related Ingredients